(Q73619342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

5 November 2019

main subject

1 reference

1 reference

1 reference

W K Evans

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C C Earle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D J Stewart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Dahrouge

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Tomiak

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Goss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D Logan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Goel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Z Gertler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Dulude

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

83-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900046-9

7 January 2021

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900046-9

7 January 2021

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900046-9

7 January 2021

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900046-9

7 January 2021

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900046-9

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900046-9

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900046-9

7 January 2021

10.1016/S0169-5002(97)00046-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9268950%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference